Compass Therapeutics Inc. (CMPX) Price Prediction & ForecastCMPXCompass Therapeutics Inc.

Alphio's CMPX stock price prediction model matches the current Compass Therapeutics Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.68 (-0.20%). The 1-week path is $0.69 (+0.58%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Compass Therapeutics Inc. (CMPX) is not a good buy. The stock is trading at $0.7675, down 85.15% year-to-date, and has an RSI of 35.791, indicating it is oversold but not necessarily a buy signal. Furthermore, the company has reported negative net income for multiple quarters, with a loss of $25,154,000 in Q2 2026. Analysts have cut their price targets significantly, with Wedbush lowering its target from $5 to $1, indicating a potential further downside of 19% from recent prices. The primary risk is the FDA's requirement for a new trial to demonstrate survival benefits for its lead drug, which complicates its approval process and could delay potential revenue.

Compass Therapeutics Inc. (CMPX) last closed at $0.6846, losing -10.24%. These facts feed the 1-day and 1-week CMPX price prediction above.